Current treatment for liver metastases from colorectal cancer

World Journal of Gastroenterology

Volumn 9, Issue 2, 2003, Pages 193-200

  Liu, Lian Xin ^a   Zhang, Wei Hui ^a   Jiang, Hong Chi ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CYTOTOXIC AGENT; EDRECOLOMAB; FLOXURIDINE; FLUOROURACIL; IMMUNOMODULATING AGENT; INTERLEUKIN 2; LEVAMISOLE; YTTRIUM 90;

ARTERY CATHETERIZATION; ARTIFICIAL EMBOLISM; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CATHETER ABLATION; CLINICAL TRIAL; COLORECTAL CANCER; CRYOTHERAPY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENTIATION; EXTRAHEPATIC DISEASE; FIRST PASS EFFECT; HEPATIC ARTERY; HUMAN; IMMUNE DEFICIENCY; IMMUNOTHERAPY; LIVER METASTASIS; LIVER RESECTION; PORTAL VEIN; PREOPERATIVE CARE; RADIOFREQUENCY ABLATION; REVIEW; SYSTEMIC DISEASE; TREATMENT FAILURE;

EID: 0037442149     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i2.193     Document Type: Review

References (126)

1. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: Systematic review and meta-analysis of randomised trials. BMJ 2002; 324: 813
2. Gwyn K, Sinicrope FA. Chemoprevention of colorectal cancer. Am J Gastroenterol 2002; 97: 13-21
3. Iyer RB, Silverman PM, DuBrow RA, Charnsangavej C. Imaging in the diagnosis, staging, and follow-up of colorectal cancer. AJR Am J Roentgenol 2002; 179: 3-13
4. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001; 96: 2992-3003
5. Landheer ML, Therasse P, Van De Velde CJ. The importance of quality assurance in surgical oncology in the treatment of colorectal cancer. Surg Oncol Clin N Am 2001; 10: 885-914
6. Li XW, Ding YQ, Cai JJ, Yang SQ, An LB, Qiao DF. Studies on mechanism of Sialy Lewis-X antigen in liver metastases of human colorectal carcinoma. World J Gastroenterol 2001; 7: 425-430
7. Zhang YL, Zhang ZS, Wu BP, Zhou DY. Early diagnosis for colorectal cancer in China. World J Gastroenterol 2002; 8: 21-25
8. Li QZ, Tuo CW, Wang B, Wu BQ, Zhang YH. Liver metastasis models of human colorectal carcinoma established in nude mice by orthotopic transplantation and their biologic characteristic. World J Gastroenterol 1998; 4: 409-411
9. Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002; 38: 1023-1033
10. Biasco G, Gallerani E. Treatment of liver metastases from colorectal cancer: What is the best approach today? Dig Liver Dis 2001; 33: 438-444
11. Yoon SS, Tanabe KK. Multidisciplinary management of metastatic colorectal cancer. Surg Oncol 1998; 7: 197-207
12. Cromheecke M, De Jong KP, Hoekstra HJ. Current treatment for colorectal cancer metastatic to the liver. Eur J Surg Oncol 1999; 25: 451-463
13. Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg 1999; 86: 158-169
14. Chiappa A, Zbar AP, Biella F, Staudacher C. Survival after repeat hepatic resection for recurrent colorectal metastases. Hepatogastroenterology 1999; 46: 1065-1070
15. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318
16. Luna-Perez P, Rodriguez-Coria DF, Arroyo B, Gonzalez-Macouzet J. The natural history of liver metastases from colorectal cancer. Arch Med Res 1998; 29: 319-324
17. Heslin MJ, Medina-Franco H, Parker M, Vickers SM, Aldrete J, Urist MM. Colorectal hepatic metastases: Resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival. Arch Surg 2001, 136: 318-323
18. Wilson SM, Adson MA. Surgical treatment of hepatic metastases from colorectal cancer. Arch Surg 1976; 111: 330-334
19. Wagner JS, Adson MA, Van Heerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984; 199: 502-508
20. Wanebo HJ, Semoglou C, Attiyeh F, Stearns MJ Jr. Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg 1978; 135: 81-85
21. Glover C, Douse P, Kane P, Karani J, Meire H, Mohammadtaghi S, Allen-Mersh TG. Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum 2002; 45: 476-484
22. Rydzewski B, Dehdashti F, Gordon BA, Teefey SA, Strasberg SM, Siegel BA. Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. AJR Am J Roentgenol 2002; 178: 353-358
23. Gruenberger T, Zhao J, King J, Chung T, Clingan PR, Morris DL. Echogenicity of liver metastases from colorectal carcinoma is an independent prognostic factor in patients treated with regional chemotherapy. Cancer 2002; 94: 1753-1759
24. Cervone A, Sardi A, Conaway GL. Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Am Surg 2000; 66: 611-615
25. Li L, Wu PH, Mo YX, Lin HG, Zheng L, Li JQ, Lu LX, Ruan CM, Chen L. CT arterial portography and CT hepatic arteriography in detection of micro liver cancer. World J Gastroenterol 1999; 5: 225-227
26. Schmidt J, Strotzer M, Fraunhofer S, Boedeker H, Zirngibl H. Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: Lesion-by-lesion analysis. World J Surg 2000; 24: 43-47
27. Okano K, Yamamoto J, Okabayashi T, Sugawara Y, Shimada K, Kosuge T, Yamasaki S, Furukawa H, Muramatsu Y. CT imaging of intrabiliary growth of colorectal liver metastases: A comparison of pathological findings of resected specimens. Br J Radiol 2002; 75: 497-501
28. Valls C, Andia E, Sanchez A, Guma A, Figueras J, Torras J, Serrano T. Hepatic metastases from colorectal cancer: Preoperative detection and assessment of resectability with helical CT. Radiology 2001; 218: 55-60
29. Park JH, Nazarian LN, Halpern EJ, Feld RI, Lev-Toaff AS, Parker L, Wechsler RJ. Comparison of unenhanced and contrast-enhanced spiral CT for assessing interval change in patients with colorectal liver metastases. Acad Radiol 2001; 8: 698-704
30. Zheng WW, Zhou KR, Chen ZW, Shen JZ, Chen CZ, Zhang SJ. Characterization of focal hepatic lesions with SPIO-enhanced MRI. World J Gastroenterol 2002; 8: 82-86
31. Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ. Hepatic lesion detection: Comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999; 210: 459-466
32. Zealley IA, Shehan SJ, Rawlinson J, Coates G, Nahmias C, Somers S. Selection of patients for resection of hepatic metastases: Improved detection of extrahepatic disease with FDG pet. Radiographics 2001; 21: S55-S69
33. Boykin KN, Zibari GB, Lilien DL, McMillan RW, Aultman DF, McDonald JC. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Am Surg 1999; 65: 1183-1185
34. Figueras J, Valls C. The use of laparoscopic ultrasonography in the preoperative study of patients with colorectal liver metastases. Ann Surg 2000; 232: 721-723
35. Parks RW, Garden OJ. Liver resection for cancer. World J Gastroenterol 2001; 7: 766-771
36. Petrowsky H, Gonen M, Jarnagin W, Lorenz M, DeMatteo R, Heinrich S, Encke A, Blumgart L, Fong Y. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: A bi-institutional analysis. Ann Surg 2002; 235: 863-871
37. Malafosse R, Penna C, Sa Cunha A, Nordlinger B. Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 2001; 12: 887-894
38. Rees M, John TG. Current status of surgery in colorectal metastases to the liver. Hepatogastroenterology 2001; 48: 341-344
39. Taylor I, Gillams AR. Colorectal liver metastases: Alternatives to resection. J R Soc Med 2000; 93: 576-579
40. Rodgers MS, McCall JL. Surgery for colorectal liver metastases with hepatic lymph node involvement: A systematic review. Br J Surg 2000; 87: 1142-1155
41. Fiorentini G, Poddie DB, Giorgi UD, Guglielminetti D, Giovanis P, Leoni M, Latino W, Dazzi C, Cariello A, Tucci D, Marangolo M. Global approach to hepatic metastases from colorectal cancer: Indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments. Med Oncol 2000; 17: 163-173
42. Yamaguchi J, Yamamoto M, Komuta K, Fujioka H, Furui JI, Kanematsu T. Hepatic resections for bilobar liver metastases from colorectal cancer. J Hepatobiliary Pancreat Surg 2000; 7: 404-409
43. Bozzetti F, Bignami P, Baratti D. Surgical strategies in colorectal cancer metastatic to the liver. Tumori 2000; 86: 1-7
44. Bozzetti F, Bignami P. Recommendation for surgical treatment of colorectal liver metastases. Ann Oncol 2000; 11: 243-244
45. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-766
46. Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000; 231: 743-751
47. Primrose JN. Treatment of colorectal metastases: Surgery, cryotherapy, or radiofrequency ablation. Gut 2002; 50: 1-5
48. Lorenz M, Staib-Sebler E, Hochmuth K, Heinrich S, Gog C, Vetter G, Encke A, Muller HH. Surgical resection of liver metastases of colorectal carcinoma: Short and long-term results. Semin Oncol 2000; 27: 112-119
49. Morris DL. Surgery for liver metastases: How many? ANZ J Surg 2002; 72: 2
50. Liu LX, Jiang HC, Piao DX. Radiofrequency ablation in liver cancer. World J Gastroenterol 2002; 8: 393-399
51. Wood BJ, Ramkaransingh JR, Fojo T, Walther MM, Libutti SK. Percutaneous tumor ablation with radiofrequency. Cancer 2002; 94: 443-451
52. Parikh AA, Curley SA, Fornage BD, Ellis LM. Radiofrequency ablation of hepatic metastases. Semin Oncol 2002; 29: 168-182
53. Choi H, Loyer EM, DuBrow RA, Kaur H, David CL, Huang S, Curley S, Charnsangavej C. Radio-frequency ablation of liver tumors: Assessment of therapeutic response and complications. Radiographics 2001; 21: S41-S54
54. Goldberg SN. Radiofrequency tumor ablation: Principles and techniques. Eur J Ultrasound 2001; 13: 129-147
55. Liu CL, Fan ST. Nonresectional therapies for hepatocellular carcinoma. Am J Surg 1997; 173: 358-365
56. Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: Long-term results. Eur Radiol 2001; 11: 914-921
57. Hager ED, Dziambor H, Hohmann D, Gallenbeck D, Stephan M, Popa C. Deep hyperthermia with radiofrequencies in patients with liver metastases from colorectal cancer. Anticancer Res 1999; 19: 3403-3408
58. Rossi S, Di Stasi M, Buscarini E, Quaretti P, Garbagnati F, Squassante L, Paties CT, Silverman DE, Buscarini L. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996; 167: 759-768
59. Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications. Ann Surg Oncol 2000; 7: 593-600
60. Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 2001; 13: 149-158
61. Machi J. Radiofrequency ablation for multiple hepatic metastases. Ann Surg Oncol 2001; 8: 379-380
62. Bilchik AJ, Wood TF, Allegra DP. Radiofrequency ablation of unresectable hepatic malignancies: Lessons learned. Oncologist 2001; 6: 24-33
63. Wong SL, Edwards MJ, Chao C, Simpson D, McMasters KM. Radiofrequency ablation for unresectable hepatic tumors. Am J Surg 2001; 182: 552-557
64. Pearson AS, Izzo F, Fleming RY, Ellis LM, Delrio P, Ron MS, Granchi J, Curley SA. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999; 178: 592-599
65. Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, Fiore F, Pignata S, Daniele B, Cremona F. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients. Ann Surg 1999; 230: 1-8
66. Gillams AR, Lees WR. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 2000; 43: 656-661
67. Sotsky TK, Ravikumar TS. Cryotherapy in the treatment of liver metastases from colorectal cancer. Semin Oncol 2002; 29: 183-191
68. Seifert JK, Achenbach T, Heintz A, Bottger TC, Junginger T. Cryotherapy for liver metastases. Int J Colorectal Dis 2000; 15: 161-166
69. Neeleman N, Wobbes T, Jager GJ, Ruers TJ. Cryosurgery as treatment modality for colorectal liver metastases. Hepatogastroenterology 2001; 48: 325-359
70. Ruers TJ, Jager GJ, Wobbes T. Cryosurgery for colorectal liver metastases. Semin Oncol 2000; 27: 120-125
71. Sikma MA, Coenen JL, Kloosterziel C, Hasselt BA, Ruers TJ. A breakthrough in cryosurgery. Surg Endosc 2002; 16: 870
72. Finlay IG, Seifert JK, Stewart GJ, Morris DL. Resection with cryotherapy of colorectal hepatic metastases has the same survival as hepatic resection alone. Eur J Surg Oncol 2002; 26: 199-202
73. Rivoire M, De Cian F, Meeus P, Gignoux B, Frering B, Kaemmerlen P. Cryosurgery as a means to improve surgical treatment of patients with multiple unresectable liver metastases. Anticancer Res 2002; 20: 3785-3790
74. Seifert JK, Morris DL. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 1998; 228: 201-208
75. Seifert JK, Morris DL. Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer. Br J Surg 1999; 86: 234-240
76. Wallace JR, Chrisitians KK, Pitt HA, Quebbeman EJ. Cryotherapy extends the indications for treatment of colorectal liver metastases. Surgery 1999; 126: 766-772
77. Huang A, McCall JM, Weston MD, Mathur P, Quinn H, Henderson DC, Allen-Mersh TG. Phase I study of percutaneous cryotherapy for colorectal liver metastasis. Br J Surg 2002; 89: 303-310
78. Gruenberger T, Jourdan JL, Zhao J, King J, Morris DL. Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases. Arch Surg 2001; 136: 1154-1157
79. Ruers TJ, Joosten J, Jager GJ, Wobbes T. Long-term results of treating hepatic colorectal metastases with cryosurgery. Br J Surg 2001; 88: 844-849
80. Ragnhammar P, Hafstrom L, Nygren P, Glimelius B. SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 2001; 40: 282-308
81. Kohne CH, Cunningham D, Di CF, Glimelius B, Blijham G, Aranda E, Scheithauer W, Rougier P, Palmer M, Wils J, Baron B, Pignatti F, Schoffski P, Micheel S, Hecker H. Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: Results of a multivariate analysis of 3825 patients. Ann Oncol 2002; 13: 308-317
82. Piedbois P, Zelek L, Cherqui D. Chemotherapy of nonoperable colorectal liver metastases. Hepatogastroenterology 2001; 48: 711-714
83. Hasuike Y, Takeda Y, Mishima H, Nishishou I, Tsujinaka T, Kikkawa N. Systemic chemotherapy for advanced colorectal cancer with liver metastasis. Gan To Kagaku Ryoho 2002; 29: 866-872
84. Ensminger WD. Intrahepatic arterial infusion of chemotherapy: Pharmacologic principles. Semin Oncol 2002; 29: 119-125
85. Van Riel JM, Van Groeningen CJ, Giaccone G, Pinedo HM. Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Oncology 2000; 59: 89-97
86. Aldrighetti L, Arru M, Angeli E, Venturini M, Salvioni M, Ronzoni M, Caterini R, Ferla G. Percutaneous vs. surgical placement of hepatic artery indwelling catheters for regional chemotherapy. Hepatogastroenterology 2002; 49: 513-517
87. Howell JD, Warren HW, Anderson JH, Kerr DJ, McArdle CS. Intra-arterial 5-fluorouracil and intravenous folinic acid in the treatment of liver metastases from colorectal cancer. Eur J Surg 1999; 165: 652-658
88. Lygidakis NJ, Sgourakis G, Safioleus MC, Nestoridis J. Regional chemoimmunotherapy for nonresectable metastatic liver disease of colorectal origin. A prospective randomized study. Hepatogastroenterology 2001; 48: 1085-1087
89. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255-1260
90. Howell JD, McArdle CS, Kerr DJ, Buckles J, Ledermann JA, Taylor I, Gallagher HJ, Budden J. A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastases. Br J Cancer 1997; 76: 1390-1393
91. Pelosi E, Bar F, Battista S, Bello M, Bucchi MC, Alabiso O, Molino G, Bisi G. Hepatic arterial infusion chemotherapy for unresectable confined liver metastases: Prediction of systemic toxicity with the application of a scintigraphic and pharmacokinetic approach. Cancer Chemother Pharmacol 1999; 44: 505-510
92. Kemeny N, Fata F. Hepatic-arterial chemotherapy. Lancet Oncol 2001; 2: 418-428
93. Weinreich DM, Alexander HR. Transarterial perfusion of liver metastases. Semin Oncol 2002; 29: 136-144
94. Sasson AR, Watson JC, Sigurdson ER. Hepatic artery infusional chemotherapy for colorectal liver metastases. Cancer Treat Res 2001; 109: 279-298
95. Mathur P, Allen-Mersh TG. Hepatic arterial chemotherapy for colorectal liver metastases. Hepatogastroenterology 2001; 48: 317-319
96. Bloom AI, Gordon RL, Ahl KH, Kerlan RK Jr, LaBerge JM, Wilson MW, Venook AP, Warren R. Transcatheter embolization for the treatment of misperfusion after hepatic artery chemoinfusion pump implantation. Ann Surg Oncol 1999; 6: 350-358
97. Kohnoe S, Endo K, Yamamoto M, Ikeda Y, Toh Y, Baba H, Tajima T, Okamura T. Protracted hepatic arterial infusion with low-dose cisplatin plus 5-fluorouracil for unresectable liver metastases from colorectal cancer. Surgery 2002; 131: S128-134
98. Link KH, Sunelaitis E, Kornmann M, Schatz M, Gansauge F, Leder G, Formentini A, Staib L, Pillasch J, Beger HG. Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival. Cancer 2001; 92: 2746-2753
99. Muller H, Nakchbandi W, Chatzissavvidis I, Valek V. Intra-arterial infusion of 5-fluorouracil plus granulocyte-macrophage colony-stimulating factor (GM-CSF) and chemoembolization with melphalan in the treatment of disseminated colorectal liver metastases. Eur J Surg Oncol 2001; 27: 652-661
100. Fiorentini G, De Giorgi U, Giovanis P, Guadagni S, Cantore M, Marangolo M. International Society of Regional Cancer Treatment and Societa Italiana di Terapie Integrate Locoregionali in Oncologia. Intra-arterial hepatic chemotherapy (IAHC) for liver metastases from colorectal cancer: Need of guidelines for catheter positioning, part management, and anti-coagulant therapy. Ann Oncol 2001; 12: 1023
101. Copur MS, Capadano M, Lynch J, Goertzen T, McCowan T, Brand R, Tempero M. Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer: A phase II trial using intermittent percutaneous hepatic arterial access. J Clin Oncol 2001; 19: 2404-2412
102. Van Riel JM, Van Groeningen CJ, Albers SH, Cazemier M, Meijer S, Bleichrodt R, Van Den Berg FG, Pinedo HM, Giaccone G. Hepatic arterial 5-fluorouracil in patients with liver metastases of colorectal cancer: Single-centre experience in 145 patients. Ann Oncol 2000; 11: 1563-1570
103. Chen MS, Li JQ, Zhang YQ, Lu LX, Zhang WZ, Yuan YF, Guo YP, Lin XJ, Li GH. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol 2002; 8: 74-78
104. Wu ZQ, Fan J, Qiu SJ, Zhou J, Tang ZY. The value of postoperative hepatic regional chemotherapy in prevention of recurrence after radical resection of primary liver cancer. World J Gastroenterol 2000; 6: 131-133
105. Huang XQ, Huang ZQ, Duan WD, Zhou NX, Feng YQ. Severe biliary complications after hepatic artery embolization. World J Gastroenterol 2002; 8: 119-123
106. Abramson RG, Rosen MP, Perry LJ, Brophy DP, Raeburn SL, Stuart KE. Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy. Radiology 2000; 216: 485-491
107. Popov I, Lavrnic S, Jelic S, Jezdic S, Jasovic A. Chemoembolization for liver metastases from colorectal carcinoma: Risk or a benefit. Neoplasma 2002; 49: 43-48
108. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, Lemoine A, Bismuth H. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000; 231: 480-486
109. Azoulay D, Castaing D, Krissat J, Smail A, Hargreaves GM, Lemoine A, Emile JF, Emile JF, Bismuth H. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 2000; 232: 665-672
110. Kemeny N, Fata F. Arterial, portal, or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma. J Hepatobiliary Pancreat Surg 1999; 6: 39-49
111. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, Ohta K, Yamaguchi T, Matsubara T, Takahashi T, Nakajima T, Muto T, Ikari T, Yanagisawa A, Kato Y. Proliferative activity of intra-hepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 2001; 34: 267-272
112. Elias D, Ouellet JF, De Baere T, Lasser P, Roche A. Preoperative selective portal vein embolization before hepatectomy for liver metastases: Long-term results and impact on survival. Surgery 2002; 131: 294-299
113. Imamura H, Kawasaki S, Miyagawa S, Ikegami T, Kitamura H, Shimada R. Aggressive surgical approach to recurrent tumors after hepatectomy for metastatic spread of colorectal cancer to the liver. Surgery 2000; 127: 528-535
114. Lode HN, Xiang R, Becker JC, Gillies SD, Reisfeld RA. Immunocytokines: A promising approach to cancer immunotherapy. Pharmacol Ther 1998; 80: 277-292
115. Okuno K, Kaneda K, Yasutomi M. Regional IL-2-based immunochemotherapy of colorectal liver metastases. Hepatogastroenterology 1999; 46: 1263-1267
116. Okuno K, Hirai N, Takemoto Y, Kawai I, Yasutomi M. Interleukin-2 as a modulator of 5-fluorouracil in hepatic arterial immunochemotherapy for liver metastases. Hepatogastroenterology 2000; 47: 487-491
117. Lou C, Chen ZN, Bian HJ, Li J, Zhou SB. Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18. World J Gastroenterol 2002; 8: 69-73
118. Buchegger F, Roth A, Allal A, Dupertuis YM, Slosman DO, Delaloye AB, Mach JP. Radioimmunotherapy of colorectal cancer liver metastases: Combination with radiotherapy. Ann N Y Acad Sci 2000; 910: 263-269
119. Buchegger F, Allal AS, Roth A, Papazyan JP, Dupertuis Y, Mirimanoff RO, Gille M, Pelegrin A, Mach JP, Slosman DO. Combined radioimmunotherapy and radiotherapy of liver metastases from colorectal cancer: A feasibility study. Anticancer Res 2000; 20: 1889-1196
120. Malik U, Mohiuddin M. External-beam radiotherapy in the management of liver metastases. Semin Oncol 2002; 29: 196-201
121. Liu L, Jiang Z, Teng GJ, Song JZ, Zhang DS, Guo QM, Fang W, He SC, Guo JH. Clinical and experimental study on regional administration of phosphorus 32 glass microspheres in treating hepatic carcinoma. World J Gastroenterol 1999; 5: 492-505
122. Gong Y, Liu KD, Zhou G, Xue Q, Chen SL, Tang ZY. Tumor radioimmunoimaging of chimeric antibody in nude mice with hepatoma xenograft. World J Gastroenterol 1998; 4: 7-9
123. Stubbs RS, Canna RJ, Mitchell AW. Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases. Hepatogastroenterol 2001; 48: 333-337
124. Stubbs RS, Cannan RJ, Mitchell AW. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases. J Gastrointest Surg 2001; 5: 294-302
125. Dancey JE, Shepherd FA, Paul K, Sniderman KW, Houle S, Gabrys J, Hendler AL, Goin JE. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med 2000; 41: 1673-1681
126. Campbell AM Bailey IH, Burton MA. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 2000; 45: 1023-1033